Furthermore, treating lung cancer cells with a physiological concentration of recombinant ghrelin (rGhrelin; 0.1nM-0.25 nM) showed no discernible effect on cancer cell proliferation and growth in a dose-dependent manner (Supplementary Fig. 3B). This evidence concerns the gene GHRL and lung carcinoma.